Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 9.3B | 8.7B | 10.1B | 8.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.6B | 3.0B | 3.1B | 3.0B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 3.8B | 3.9B | 4.3B | 3.5B |
Tax provision | 1.2B | 1.1B | 1.4B | 1.2B |
Net income | 2.6B | 2.7B | 2.9B | 2.3B |
Basic EPS | 0.4 | 0.4 | 0.5 | 0.4 |
Diluted EPS | 0.4 | 0.4 | 0.5 | 0.4 |
Basic average shares | 6.1B | 6.0B | 5.9B | 5.8B |
Diluted average shares | 6.1B | 6.0B | 5.9B | 5.8B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -155M | -105M | -154M | -107M |
Preferred stock dividends | — | — | — | 87M |